US20030201177A1 - Hemoglobin sensor - Google Patents

Hemoglobin sensor Download PDF

Info

Publication number
US20030201177A1
US20030201177A1 US10/443,269 US44326903A US2003201177A1 US 20030201177 A1 US20030201177 A1 US 20030201177A1 US 44326903 A US44326903 A US 44326903A US 2003201177 A1 US2003201177 A1 US 2003201177A1
Authority
US
United States
Prior art keywords
electrode
contact
silver
hemoglobin
sensing chamber
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/443,269
Inventor
Alastair Hodges
Ron Chatelier
Thomas Beck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/AU1996/000723 external-priority patent/WO1997018465A1/en
Priority claimed from US09/314,251 external-priority patent/US6174420B1/en
Application filed by Individual filed Critical Individual
Priority to US10/443,269 priority Critical patent/US20030201177A1/en
Publication of US20030201177A1 publication Critical patent/US20030201177A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/001Enzyme electrodes
    • C12Q1/004Enzyme electrodes mediator-assisted
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/001Enzyme electrodes
    • C12Q1/005Enzyme electrodes involving specific analytes or enzymes
    • C12Q1/006Enzyme electrodes involving specific analytes or enzymes for glucose
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/84Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH

Definitions

  • PCT/AU96/00723 which has an International filing date of Nov. 15, 1996, which designated the United States of America, and which was published by the International Bureau in English on May 22, 1997, and claims the benefit of Australian Provisional Patent application Ser. No. PN 6619, filed Nov. 16, 1995.
  • application Ser. No. 08/068,828 is the national phase under 35 U.S.C. ⁇ 371 of prior PCT International Application No. PCT/AU96/00724 which has an International filing date of Nov. 15, 1996, which designated the United States of America, and which was published by the International Bureau in English on May 22, 1997, and claims the benefit of Australian Provisional Patent application Ser. No. PN 6619, filed Nov. 16, 1995.
  • the contents of each patent and application as recited above to which priority is claimed is hereby incorporated by reference in its entirety.
  • the present invention relates to a device and method for measuring the level of hemoglobin in a blood sample.
  • the device comprises a disposable electrochemical cell containing an agent which lyses red blood cells and a reagent capable of being reduced by hemoglobin.
  • Hemoglobin is a respiratory molecule found in red blood cells. It is responsible for transporting oxygen from the lungs to body cells and for transporting carbon dioxide from body cells to the lungs. Hemoglobin has a molecular weight of 68,000 and contains four polypeptide chains. Each chain binds to a heme group which consists of a tetrapyrrole ring chelated to an Fe +2 ion. hi the lungs, the iron atoms of the hemoglobin molecule reversibly combine with an oxygen molecule, which is then transported to body cells as blood circulates. The oxygen is released from the hemoglobin molecule in the tissues, then the oxygen-free hemoglobin molecule picks up carbon dioxide which is transported back to the lungs, where it is released.
  • Hemoglobin is produced in cells in the bone marrow that become red blood cells. Certain illnesses result in a deficiency of hemoglobin, such as anemia and sickle cell disease. Still other diseases, such as polycythemia or erythrocytosis, result in excessive levels of hemoglobin. Therefore, as an aid in the diagnosis or monitoring of such diseases, a method and device for determining the concentration of hemoglobin in whole blood is desirable.
  • Numerous methods and devices for the determination of hemoglobin are known. These methods include both direct analysis, i.e., analysis without prior modification of the hemoglobin, and indirect analysis.
  • An example of a direct analysis method is the Tallquist Method, wherein a measurement of the transmission or reflection optical density of the red color imparted by oxyhemoglobin, one form of hemoglobin, is obtained.
  • An example of an indirect analysis method is Drabkin's Method. In this method, the iron in hemoglobin is oxidized with a ferricyanide to form methemoglobin, which is converted with a cyanide to cyanmethemoglobin, which is then measured spectrometrically. Both of these methods have the disadvantage of requiring expensive analytical instrumentation and complicated sample preparation. Therefore, a quick, simple, and inexpensive device and method for measuring hemoglobin that overcomes the deficiencies of prior art methods is desirable.
  • the present invention provides a device and method for measuring hemoglobin with a disposable sensing element, suitable for a single use, that can be combined with a meter to give a robust, fast, and easy to use test that is amenable to field as well as laboratory use.
  • the invention relates to the use of an electrochemical sensor that utilizes a redox agent that reacts with hemoglobin to produce an electrochemically detectable signal.
  • the method of the present invention measures total hemoglobin, oxygenated plus unoxygenated, in contrast to spectrophotometric methods wherein the hemoglobin must be converted to a single form in a separate chemical step, e.g., oxidation of hemoglobin containing Fe +2 to methemoglobin containing Fe +3 .
  • Measurement of hemoglobin by the method of the present invention is not dependent upon the extent of glycosylation or oxygenation of the hemoglobin present in the sample.
  • a device for detecting a presence or an absence of hemoglobin in an aqueous sample including an electrochemical cell having a sensing chamber, a first electrode, a second electrode, an aperture for admitting the sample into the sensing chamber, and a reagent contained within the sensing chamber wherein the reagent is capable of being reduced by hemoglobin to generate an electrical signal indicative of the presence or absence of hemoglobin.
  • the electrochemical cell may be designed to be disposed of after use in a single experiment.
  • first electrode is a sensing electrode.
  • the sensing electrode may be platinum, palladium, carbon, indium oxide, tin oxide, gold, iridium, copper, steel, silver, or mixtures thereof.
  • the first electrode may be formed by a technique including sputtering, vapor coating, screen printing, thermal evaporation, ink jet printing, ultrasonic spraying, slot coating, gravure printing or lithography.
  • the second electrode is a counter electrode.
  • the second electrode may be a metal in contact with a metal salt, for example, silver in contact with silver chloride, silver in contact with silver bromide, silver in contact with silver iodide, mercury in contact with mercurous chloride, and mercury in contact with mercurous sulfate.
  • the second electrode may also be a reference electrode.
  • the electrochemical cell further includes a third electrode, which may be a reference electrode.
  • the third electrode may include a metal in contact with a metal salt, for example, silver in contact with silver chloride, silver in contact with silver bromide, silver in contact with silver iodide, mercury in contact with mercurous chloride, and mercury in contact with mercurous sulfate.
  • the reagent may include dichromate, vanadium oxides, permanganate, electroactive organometallic complexes, quinones, dichlorophenolindophenol, and ferricyanide.
  • a buffer such as a phosphate, carbonate, alkali metal salt of mellitic acid, or alkali metal salt of citric acid, may be contained within the sensing chamber.
  • the sensing chamber further includes a red blood cell lysing agent, for example, one selected from ionic detergents, nonionic detergents, proteolytic enzymes, lipases, saponin, sodium dodecyl sulfate, cetyl trimethylammonium bromide, or polyethoxylated octylphenol.
  • a red blood cell lysing agent for example, one selected from ionic detergents, nonionic detergents, proteolytic enzymes, lipases, saponin, sodium dodecyl sulfate, cetyl trimethylammonium bromide, or polyethoxylated octylphenol.
  • the sample includes whole blood.
  • the sensing chamber further includes a support contained within the sensing chamber, for example, mesh, nonwoven sheet, fibrous filler, macroporous membrane, sintered powder, or combinations thereof.
  • the reagent, red blood cell lysing agent, and/or buffer may be contained within or supported on the support.
  • the second electrode is mounted in opposing relationship a distance of less than about 500 microns from the first electrode; less than about 150 microns from the first electrode; or less than about 150 microns and greater than about 50 microns from the first electrode.
  • the device includes an interface for communication with a meter.
  • the interface may communicate a voltage or a current.
  • the electrochemical cell may be a thin layer electrochemical cell.
  • a method for detecting a presence or an absence of hemoglobin in an aqueous sample including providing a device including an electrochemical cell having a sensing chamber, a first electrode, a second electrode, an aperture for admitting the sample into the sensing chamber, and a reagent contained within the sensing chamber, wherein the reagent is capable of being reduced by hemoglobin to generate an electrical signal indicative of the presence or absence of hemoglobin; providing an aqueous sample; allowing the sample to flow through the aperture and into the sensing chamber, such that the first and second electrodes are substantially covered; and obtaining an electrochemical measurement indicative of the presence or absence of hemoglobin present in the sample.
  • the electrochemical cell is designed to be disposed of after use in a single experiment, or may be a thin layer electrochemical cell.
  • the electrochemical measurement may be an amperometric measurement, a potentiometric measurement, a coulometric measurement, or a quantitative measurement.
  • a method for measuring hemoglobin in a fluid whole blood sample, the whole blood sample containing red blood cells, the red blood cells containing hemoglobin, wherein the method includes providing a device including an electrochemical cell having a sensing chamber, a first electrode, a second electrode, an aperture for admitting the sample into the sensing chamber; a reagent contained within the sensing chamber and capable of being reduced by hemoglobin; and a red blood cell lysing agent contained within the sensing chamber; placing the whole blood sample in the sensing chamber, whereby the lysing agent contained within the sensing chamber releases hemoglobin from the red blood cells, whereby the hemoglobin thus released reduces the reagent; and obtaining an electrochemical measurement indicative of the level of hemoglobin present in the whole blood sample.
  • the electrochemical cell is designed to be disposed of after use in a single experiment, or may be a thin layer electrochemical cell.
  • the method further includes obtaining an electrochemical measurement indicative of the presence or absence of hemoglobin in the sample by applying a negative potential to the first electrode; measuring a current generated by reaction of the reagent and hemoglobin; analyzing the current to give a result, the result including a time required for substantial lysis of the red blood cells or a derived final value for the current; calculating a percentage of the reaction completed as a function of time based on the result,of the analyzing step; reversing the potential on the first electrode; measuring a transient current; and determining a diffusion coefficient and a concentration of a reduced form of the reagent based on the transient current.
  • a method of manufacture of a device for detecting the presence or absence of hemoglobin in an aqueous sample including an electrochemical cell having a sensing chamber, a first electrode, a second electrode, an aperture for admitting the sample into the sensing chamber, and a reagent contained within the sensing chamber, and wherein the reagent is capable of being reduced by hemoglobin to generate an electrical signal indicative of the presence or absence of hemoglobin, the method including forming an aperture extending through a sheet of electrically resistive material, the aperture defining a side wall of the sensing chamber; mounting a first layer having a first electrode to a first side of the sheet and extending over the aperture whereby to define a first sensing chamber end wall, the first electrode facing the first side of the sheet; mounting a second layer having a second electrode to a second side of the sheet and extending over the aperture whereby to define a second sensing chamber end wall in substantial overlying registration with the first layer,
  • the method further includes the step of providing a vent in the strip to permit the escape of air displaced from the sensing chamber as sample fills the sensing chamber.
  • the aperture is of a rectangular cross-section.
  • At least one of the electrodes includes a noble metal, such as palladium, platinum, and silver. At least one of the electrodes may be a sputter coated metal deposit. The electrodes may be adhered to the sheet, for example, by an adhesive such as a heat activated adhesive, pressure sensitive adhesive, heat cured adhesive, chemically cured adhesive, hot melt adhesive, and hot flow adhesive.
  • a noble metal such as palladium, platinum, and silver.
  • At least one of the electrodes may be a sputter coated metal deposit.
  • the electrodes may be adhered to the sheet, for example, by an adhesive such as a heat activated adhesive, pressure sensitive adhesive, heat cured adhesive, chemically cured adhesive, hot melt adhesive, and hot flow adhesive.
  • the method may include the step of providing a buffer and/or a red blood cell lysing agent contained within the sensing chamber.
  • the reagent and/or buffer may be printed onto at least one wall of the sensing chamber.
  • a support contained within the sensing chamber may also be provided, such as mesh, fibrous filler, macroporous membrane, sintered powder, or combinations thereof.
  • the reagent may be supported on or contained within the support.
  • At least the sheet or one of the layers includes a polymeric material selected from polyester, polystyrene, polycarbonate, polyolefin, and mixtures thereof, or polyethylene terephthalate.
  • the second electrode is mounted in opposing relationship a distance of less than about 500 microns from the first electrode; less than about 150 microns from the first electrode; or less than about 150 microns and greater than about 50 microns from the first electrode.
  • the electrochemical cell is designed to be disposed of after use in a single experiment.
  • FIG. 1 shows a plan view of an electrochemical cell.
  • FIG. 2 shows a cross-section view on line 10 - 10 of FIG. 1.
  • FIG. 3 shows an end-section view on line 11 - 11 of FIG. 1.
  • a method and device for measuring hemoglobin levels in a fluid whole blood sample is provided. If the whole blood sample is not in liquid form, i.e., dried blood, it can be analyzed after solid sample is mixed into a suitable fluid, e.g., water. Whole blood contained within a solid tissue sample may be analyzed after extraction using techniques well-known in the art.
  • hemoglobin Prior to its analysis, hemoglobin must be released from the red blood cells in which it is contained. This may be accomplished by pretreating the whole blood sample with a lysing agent prior to its introduction into the electrochemical cell. Alternatively, a lysing agent may be contained within the electrochemical cell itself. Other agents may also be used to pretreat the sample. For example, pH may be adjusted to a desired level by means of a buffer or neutralizing agent, or a substance that renders interfering species nonreactive may be added.
  • the electrochemical cell of the present invention is disposable and designed for use in a single experiment.
  • the electrochemical cell is a thin layer sensor such as that disclosed in U.S. Pat. No. 5,942,102 (incorporated herein by reference in its entirety).
  • the term “thin layer electrochemical cell” refers to a cell having closely spaced electrodes such that reaction products from the counter electrode arrive at the working electrode.
  • the separation of electrodes in such a cell for measuring glucose in blood will be less than 500 microns, and preferably less than 200 microns.
  • FIGS. 1, 2, and 3 A preferred embodiment of such an electrochemical cell is illustrated in FIGS. 1, 2, and 3 .
  • the cell illustrated in FIGS. 1, 2, and 3 includes a polyester core 4 having a circular aperture 8 .
  • Aperture 8 defines a cylindrical cell side wall 12 .
  • Adhered to one side of core 4 is a polyester sheet 1 having a sputter coating of palladium 2 .
  • the sheet is adhered by means of an adhesive 3 to core 4 with palladium 2 adjacent core 4 and covering aperture 8 .
  • a second polyester sheet 7 having a second sputter coating of palladium 6 is adhered by means of contact adhesive 5 to the other side of core 4 and covering aperture 8 .
  • the assembly is notched at 9 to provide for a solution to be admitted to the cell or to be drawn in by wicking or capillary action and to allow air to escape.
  • the metal films 2 , 6 are connected with suitable electrical connections or formations whereby potentials may be applied and currently measured.
  • Such a thin layer electrochemical cell is prepared by first forming an aperture extending through a sheet of electrically resistive material, the aperture defining a side wall of the electrochemical cell.
  • Suitable electrically resistive materials which may be used in the sheet containing the aperture, or in other layers in the cell, include, for example, materials such as polyesters, polystyrenes, polycarbonates, polyolefins, polyethylene terephthalate, mixtures thereof, and the like.
  • the aperture in the sheet is rectangular, however other shapes, e.g., circular, may be used as well.
  • a first thin electrode layer is then mounted on one side of the sheet of electrically resistive material, extending over the aperture and forming an end wall.
  • the layer may be adhered to the sheet, for example, by means of an adhesive.
  • Suitable adhesives include, for example, heat activated adhesives, pressure sensitive adhesives, heat cured adhesives, chemically cured adhesives, hot melt adhesives, hot flow adhesives, and the like.
  • the electrode layer is prepared by coating (e.g., by sputter coating) a sheet of electrically resistive material with a suitable metal, for example, palladium.
  • a second thin electrode layer is then mounted on the opposite side of the electrically resistive material, also extending over the aperture, so as to form a second end wall.
  • the electrode layers are mounted in opposing relationship at a distance of less than about 1 millimeter, desirably less than about 800 microns, more desirably less that about 600, or preferably less than about 500 microns, more preferably less than about 300 to 150 microns, more preferably less than 150 microns, and most preferably between 25, 40, 50, 100 and 150 microns.
  • a second aperture or ingress is then provided for liquid to enter the cell. Such an ingress can be provided by forming a notch along one edge of the device which extends through the electrode layers and aperture.
  • the electrode layers are provided with connection means allowing the sensors to be placed in a measuring circuit.
  • Chemicals for use in the cell may be supported on the cell electrodes or walls, on one or more independent supports contained within cell, or may be self supporting. If the chemicals are to be supported on the cell electrodes or walls, the chemicals may be applied by use of application techniques well known in the art, such as ink jet printing, screen printing, lithography, ultrasonic spraying, slot coating, gravure printing, and the like. Suitable independent supports may include, but are not limited to, meshes, nonwoven sheets, fibrous fillers, macroporous membranes, and sintered powders. The chemicals for use in the cell may be supported on or contained within a support.
  • the materials used within the cell as well as the materials used to construct the cell are in a form amenable to mass production, and the cells themselves are designed to be able to be used for a single experiment then disposed of.
  • a disposable cell is one that is inexpensive enough to produce that it is economically acceptable to be used only for a single test. Secondly, that the cell may conveniently only be used for a single test. Inconveniently in this context means that steps such as washing and/or reloading of reagents would need to be taken to process the cell after a single use to render it suitable for a subsequent use.
  • the perceived value of the result of the test to the user is the same or greater than the cost of the cell to purchase and use, the cell purchase price being set by the cost of supplying the cell to the user plus an appropriate mark up.
  • the cells have relatively low materials costs and simple fabrication processes.
  • the electrode materials of the cells should be inexpensive, such as carbon, or be used in sufficiently small amounts such that expensive materials may be used. Screen printing carbon or silver ink is a process suitable for forming electrodes with relatively inexpensive materials.
  • Electrode materials such as platinum, palladium, gold or iridium
  • methods with better material utilization such as sputtering or evaporative vapor coating, are more suitable as they may give extremely thin films.
  • the substrate materials for the disposable cells also need to be inexpensive. Examples of such inexpensive materials are polymers such as polyvinylchloride, polyimide, polyester and coated papers and cardboard.
  • Cell assembly methods also need to be amenable to mass production. These methods include fabricating multiple cells on cards and separating the card into individual strips subsequent to the main assembly steps, and web fabrication where the cells are produced on a continuous web, which is subsequently separated into individual strips. Card processes are most suitable when close spatial registration of multiple features is required for the fabrication and/or when stiff cell substrate materials are to be used. Web processes are most suitable when the down web registration of features is not as critical and flexible webs may be used.
  • the convenient single use requirement for the disposable cell is desirable so that users are not tempted to try to reuse the cell and possibly obtain an inaccurate test result.
  • the single use requirement for the cell may be stated in user instructions accompanying the cell.
  • the cell may also be fabricated such that using the cell more than once is difficult or not possible. This may be accomplished, for example, by including reagents that are washed away or consumed during the first test and so are not functional in a second test.
  • the signal of the test may be examined for indications that reagents in the cell have already reacted, such as an abnormally high initial signal, and the test aborted.
  • Another method includes providing a means for breaking electrical connections in the cell after the first test in a cell has been completed.
  • At least one of the electrodes in the cell is a sensing electrode, defined as an electrode sensitive to the amount of oxidized redox agent.
  • a sensing electrode defined as an electrode sensitive to the amount of oxidized redox agent.
  • a second electrode acting as reference electrode is present which acts to provide a reference potential.
  • At least one other electrode is present which functions as a counter electrode to complete the electrical circuit.
  • This second electrode may also function as a reference electrode.
  • a separate electrode may perform the function of a reference electrode.
  • Materials suitable for the sensing, counter, and reference electrodes must be compatible with the redox reagents present in the device. Compatible materials will not react chemically with the redox reagent or any other substance present in the cell. Examples of such suitable materials include, but are not limited to, platinum, palladium, carbon, indium oxide, tin oxide, mixed indium/tin oxides, gold, silver, iridium and mixtures thereof. These materials may be formed into electrode structures by any suitable method, for example, by sputtering, vapor coating, screen printing, thermal evaporation or lithography. In preferred embodiments, the material is sputtered or screen printed to form the electrode structures.
  • Non-limiting examples of materials suitable for use in the reference electrode include metal/metal salt systems such as silver in contact with silver chloride, silver bromide or silver iodide, and mercury in contact mercurous chloride or mercurous sulfate.
  • the metal may be deposited by any suitable method and then brought into contact with the appropriate metal salt. Suitable methods include, for example, electrolysis in a suitable salt solution or chemical oxidation.
  • Such metal/metal salt systems provide better potential control in potentiometric measurement methods than do single metal component systems.
  • the metal/metal salt electrode systems are used as a separate reference electrode in an amperometric sensor.
  • Suitable red blood cell lysing agents include detergents, both ionic and non-ionic, proteolytic enzymes, and lipases.
  • Suitable ionic detergents include, for example, sodium dodecyl sulfate and cetyl trimethylammonium bromide.
  • proteolytic enzymes include trypsin, chymotrypsin, pepsin, papain, and Pronase E, a very active enzyme having broad specificity.
  • Nonionic surfactants suitable for use include, e.g., ethoxylated octylphenols, including the Triton X Series available from Rohm & Haas of Philadelphia, Pa.
  • saponins i.e., plant glycosides that foam in water, are used as the lysing agent.
  • Suitable redox reagents include those which are capable of oxidizing hemoglobin.
  • Examples of redox reagents suitable for use in analyzing hemoglobin include, but are not limited, to salts of ferricyanide, dichromate, vanadium oxides, permanganate, and electroactive organometallic complexes.
  • Organic redox reagents such as dichlorophenolindophenol, and quinones are also suitable.
  • the redox reagent for analyzing hemoglobin is ferricyanide.
  • a buffer may be present along with the redox reagent in dried form in the electrochemical cell. If a buffer is used, it is present in an amount such that the resulting pH level is suitable for adjusting the oxidizing potential of the redox reagent to a level suitable for oxidizing hemoglobin but not other species that it is not desired to detect.
  • the buffer is present in a sufficient amount so as to substantially maintain the pH of the sample at the desired level during the test.
  • buffers suitable for use include phosphates, carbonates, alkali metal salts of mellitic acid, and alkali metal salts of citric acid. The choice of buffer will depend on the desired pH. The buffer is selected so as not to react with the redox reagent.
  • redox reagents and buffers other substances may also be present within the electrochemical cell.
  • substances include, for example, viscosity enhancers and low molecular weight polymers.
  • Hydrophilic substances may also be contained within the cell, such as polyethylene glycol, polyacrylic acid, dextran, and surfactants such as those marketed by Rohm & Haas Company of Philadelphia, Pa., under the trade name TritonTM or by ICI Americas Inc. of Wilmington, Del., under the trade name TweenTM.
  • Such substances may enhance the fill rate of the cell, provide a more stable measurement, and inhibit evaporation in small volume samples.
  • the sample In measuring hemoglobin present in a whole blood sample, the sample is introduced into the sensor cell, whereupon the sample dissolves the dried reagents and other substances present in the sensor cell. If the sample has not been pretreated with a lysing agent, a lysing agent present in the sensor cell releases hemoglobin from the red blood cells. The redox reagent then reacts with hemoglobin present in the sample to form the reduced form of the redox reagent. In the case of a potentiometric sensor, the resulting ratio of oxidized to reduced form of the redox reagent fixes the potential of the sensing electrode relative to the reference electrode. This potential is then used as a measure of the concentration of the hemoglobin originally in the sample.
  • the sensing cell is operated as an amperometric sensor.
  • the reduced redox reagent formed by reaction with hemoglobin is electrochemically oxidized at the sensing electrode.
  • the current resulting from this electrochemical reaction is then used to measure the concentration of hemoglobin originally in the sample.
  • the sensor is operated in potentiometric or coulometric mode.
  • the cell's electrodes are used to produce an electrical signal, i.e., a voltage or current, readable by an attached meter.
  • an interface for connecting the cell to the meter is provided.
  • the meter may display the measurement in a visual, audio or other form, or may store the measurement in electronic form.
  • a typical concentration of hemoglobin e.g., 14 g/dL, would yield a ferrocyanide concentration of 8.2 mM upon oxidation.
  • the minimum detectable limit in a preferred embodiment of the method and device is approximately 0.1 mM.
  • substantially complete lysis of all red blood cells is achieved before measurement of hemoglobin.
  • a rapid hemoglobin measurement may be obtained even if the lysis step proceeds slowly by using a first and second potential application step.
  • a sensor configuration as described above is used, e.g., a sensor wherein the bottom electrode is palladium, upon which the dried reagents are deposited, and wherein the top electrode is a gold electrode.
  • the first potential is applied by applying a ⁇ 0.3 V potential at zero time to set the gold electrode as the working electrode.
  • the increase in current can be used in a number of ways: to assess the time required for full lysis and reaction, to extrapolate the signal to longer times, or to assess the fraction of hemoglobin reacted at a given time. The first method gives some quality assurance, and the second and third methods yield a shorter test.
  • the potential can be reversed to +0.3 V and the reverse transient current can be measured and analyzed using electrochemical methods known in the art, e.g., as disclosed in U.S. application Ser. No. 08/981385 filed Apr. 17, 1998, and U.S. Pat. No. 5,942,102 (both incorporated herein by reference in their entirety), to calculate the diffusion coefficient and concentration of ferrocyanide.
  • the first potential application may also be used to subtract interferents.
  • the ferricyanide reacts more quickly with interfering substances which are free in the plasma than with hemoglobin which is packaged in red blood cells.
  • the ratio of the minimum to maximum (or extrapolated) currents resulting from the first potential application may be used to yield the concentration of reduced mediator measured by the second potential pulse (at +0.3 V), thereby yielding a more accurate, corrected concentration of hemoglobin.
  • the simplest correction would be:
  • [Hb]′ is the corrected concentration of hemoglobin
  • [Hb] is the uncorrected concentration of hemoglobin
  • imin is the measured current
  • imax is the extrapolated current resulting from the first potential application.

Abstract

The present invention relates to a device and method for measuring hemoglobin in a fluid sample. The device comprises a disposable electrochemical cell, such as a thin layer electrochemical cell, containing a reagent capable of being reduced by hemoglobin. A suitable fluid sample that may be analyzed according the present invention is whole blood. If the hemoglobin to be analyzed is present in red blood cells, a lysing agent may be added to the sample to release the hemoglobin prior to analysis.

Description

    RELATED APPLICATION
  • This application is a continuation of application Ser. No. 09/616,512, filed Jul. 14, 2000, which is a continuation-in-part of application Ser. No. 09/314,251, filed May 18, 1999, now U.S. Pat. No. 6,174,420. application Ser. No. 09/314,251 is a continuation of application Ser. No. 08/852,804, filed May 7, 1997, now U.S. Pat. No. 5,942,102, and a continuation of application Ser. No. 08/068,828, filed Mar. 15, 1999, now U.S. Pat. No. 6,179,979. application Ser. No. 08/852,804 is the national phase under 35 U.S.C. §371 of prior PCT International application Ser. No. PCT/AU96/00723 which has an International filing date of Nov. 15, 1996, which designated the United States of America, and which was published by the International Bureau in English on May 22, 1997, and claims the benefit of Australian Provisional Patent application Ser. No. PN 6619, filed Nov. 16, 1995. application Ser. No. 08/068,828 is the national phase under 35 U.S.C. §371 of prior PCT International Application No. PCT/AU96/00724 which has an International filing date of Nov. 15, 1996, which designated the United States of America, and which was published by the International Bureau in English on May 22, 1997, and claims the benefit of Australian Provisional Patent application Ser. No. PN 6619, filed Nov. 16, 1995. The contents of each patent and application as recited above to which priority is claimed is hereby incorporated by reference in its entirety.[0001]
  • FIELD OF THE INVENTION
  • The present invention relates to a device and method for measuring the level of hemoglobin in a blood sample. The device comprises a disposable electrochemical cell containing an agent which lyses red blood cells and a reagent capable of being reduced by hemoglobin. [0002]
  • BACKGROUND OF THE INVENTION
  • Hemoglobin is a respiratory molecule found in red blood cells. It is responsible for transporting oxygen from the lungs to body cells and for transporting carbon dioxide from body cells to the lungs. Hemoglobin has a molecular weight of 68,000 and contains four polypeptide chains. Each chain binds to a heme group which consists of a tetrapyrrole ring chelated to an Fe[0003] +2 ion. hi the lungs, the iron atoms of the hemoglobin molecule reversibly combine with an oxygen molecule, which is then transported to body cells as blood circulates. The oxygen is released from the hemoglobin molecule in the tissues, then the oxygen-free hemoglobin molecule picks up carbon dioxide which is transported back to the lungs, where it is released.
  • Hemoglobin is produced in cells in the bone marrow that become red blood cells. Certain illnesses result in a deficiency of hemoglobin, such as anemia and sickle cell disease. Still other diseases, such as polycythemia or erythrocytosis, result in excessive levels of hemoglobin. Therefore, as an aid in the diagnosis or monitoring of such diseases, a method and device for determining the concentration of hemoglobin in whole blood is desirable. [0004]
  • Numerous methods and devices for the determination of hemoglobin are known. These methods include both direct analysis, i.e., analysis without prior modification of the hemoglobin, and indirect analysis. An example of a direct analysis method is the Tallquist Method, wherein a measurement of the transmission or reflection optical density of the red color imparted by oxyhemoglobin, one form of hemoglobin, is obtained. An example of an indirect analysis method is Drabkin's Method. In this method, the iron in hemoglobin is oxidized with a ferricyanide to form methemoglobin, which is converted with a cyanide to cyanmethemoglobin, which is then measured spectrometrically. Both of these methods have the disadvantage of requiring expensive analytical instrumentation and complicated sample preparation. Therefore, a quick, simple, and inexpensive device and method for measuring hemoglobin that overcomes the deficiencies of prior art methods is desirable. [0005]
  • SUMMARY OF THE INVENTION
  • The present invention provides a device and method for measuring hemoglobin with a disposable sensing element, suitable for a single use, that can be combined with a meter to give a robust, fast, and easy to use test that is amenable to field as well as laboratory use. In particular, the invention relates to the use of an electrochemical sensor that utilizes a redox agent that reacts with hemoglobin to produce an electrochemically detectable signal. The method of the present invention measures total hemoglobin, oxygenated plus unoxygenated, in contrast to spectrophotometric methods wherein the hemoglobin must be converted to a single form in a separate chemical step, e.g., oxidation of hemoglobin containing Fe[0006] +2 to methemoglobin containing Fe+3. Measurement of hemoglobin by the method of the present invention is not dependent upon the extent of glycosylation or oxygenation of the hemoglobin present in the sample.
  • In a first aspect of the present invention, a device for detecting a presence or an absence of hemoglobin in an aqueous sample is provided, the device including an electrochemical cell having a sensing chamber, a first electrode, a second electrode, an aperture for admitting the sample into the sensing chamber, and a reagent contained within the sensing chamber wherein the reagent is capable of being reduced by hemoglobin to generate an electrical signal indicative of the presence or absence of hemoglobin. The electrochemical cell may be designed to be disposed of after use in a single experiment. [0007]
  • In one aspect of this embodiment, first electrode is a sensing electrode. The sensing electrode may be platinum, palladium, carbon, indium oxide, tin oxide, gold, iridium, copper, steel, silver, or mixtures thereof. The first electrode may be formed by a technique including sputtering, vapor coating, screen printing, thermal evaporation, ink jet printing, ultrasonic spraying, slot coating, gravure printing or lithography. [0008]
  • In another aspect of this embodiment, the second electrode is a counter electrode. The second electrode may be a metal in contact with a metal salt, for example, silver in contact with silver chloride, silver in contact with silver bromide, silver in contact with silver iodide, mercury in contact with mercurous chloride, and mercury in contact with mercurous sulfate. The second electrode may also be a reference electrode. [0009]
  • In another aspect of this embodiment, the electrochemical cell further includes a third electrode, which may be a reference electrode. The third electrode may include a metal in contact with a metal salt, for example, silver in contact with silver chloride, silver in contact with silver bromide, silver in contact with silver iodide, mercury in contact with mercurous chloride, and mercury in contact with mercurous sulfate. [0010]
  • In another aspect of this embodiment, the reagent may include dichromate, vanadium oxides, permanganate, electroactive organometallic complexes, quinones, dichlorophenolindophenol, and ferricyanide. A buffer, such as a phosphate, carbonate, alkali metal salt of mellitic acid, or alkali metal salt of citric acid, may be contained within the sensing chamber. The sensing chamber further includes a red blood cell lysing agent, for example, one selected from ionic detergents, nonionic detergents, proteolytic enzymes, lipases, saponin, sodium dodecyl sulfate, cetyl trimethylammonium bromide, or polyethoxylated octylphenol. [0011]
  • In another aspect of this embodiment, the sample includes whole blood. [0012]
  • In another aspect of this embodiment, the sensing chamber further includes a support contained within the sensing chamber, for example, mesh, nonwoven sheet, fibrous filler, macroporous membrane, sintered powder, or combinations thereof. The reagent, red blood cell lysing agent, and/or buffer may be contained within or supported on the support. [0013]
  • In another aspect of this embodiment, the second electrode is mounted in opposing relationship a distance of less than about 500 microns from the first electrode; less than about 150 microns from the first electrode; or less than about 150 microns and greater than about 50 microns from the first electrode. [0014]
  • In another aspect of this embodiment, the device includes an interface for communication with a meter. The interface may communicate a voltage or a current. The electrochemical cell may be a thin layer electrochemical cell. [0015]
  • In a second aspect of the present invention, a method for detecting a presence or an absence of hemoglobin in an aqueous sample is provided, the method including providing a device including an electrochemical cell having a sensing chamber, a first electrode, a second electrode, an aperture for admitting the sample into the sensing chamber, and a reagent contained within the sensing chamber, wherein the reagent is capable of being reduced by hemoglobin to generate an electrical signal indicative of the presence or absence of hemoglobin; providing an aqueous sample; allowing the sample to flow through the aperture and into the sensing chamber, such that the first and second electrodes are substantially covered; and obtaining an electrochemical measurement indicative of the presence or absence of hemoglobin present in the sample. [0016]
  • In one aspect of this embodiment, the electrochemical cell is designed to be disposed of after use in a single experiment, or may be a thin layer electrochemical cell. The electrochemical measurement may be an amperometric measurement, a potentiometric measurement, a coulometric measurement, or a quantitative measurement. [0017]
  • In a third aspect of the present invention, a method is provided for measuring hemoglobin in a fluid whole blood sample, the whole blood sample containing red blood cells, the red blood cells containing hemoglobin, wherein the method includes providing a device including an electrochemical cell having a sensing chamber, a first electrode, a second electrode, an aperture for admitting the sample into the sensing chamber; a reagent contained within the sensing chamber and capable of being reduced by hemoglobin; and a red blood cell lysing agent contained within the sensing chamber; placing the whole blood sample in the sensing chamber, whereby the lysing agent contained within the sensing chamber releases hemoglobin from the red blood cells, whereby the hemoglobin thus released reduces the reagent; and obtaining an electrochemical measurement indicative of the level of hemoglobin present in the whole blood sample. [0018]
  • In one aspect of this embodiment, the electrochemical cell is designed to be disposed of after use in a single experiment, or may be a thin layer electrochemical cell. [0019]
  • In one aspect of this embodiment, the method further includes obtaining an electrochemical measurement indicative of the presence or absence of hemoglobin in the sample by applying a negative potential to the first electrode; measuring a current generated by reaction of the reagent and hemoglobin; analyzing the current to give a result, the result including a time required for substantial lysis of the red blood cells or a derived final value for the current; calculating a percentage of the reaction completed as a function of time based on the result,of the analyzing step; reversing the potential on the first electrode; measuring a transient current; and determining a diffusion coefficient and a concentration of a reduced form of the reagent based on the transient current. [0020]
  • In a fourth aspect of the present invention, a method of manufacture of a device for detecting the presence or absence of hemoglobin in an aqueous sample is provided, the device including an electrochemical cell having a sensing chamber, a first electrode, a second electrode, an aperture for admitting the sample into the sensing chamber, and a reagent contained within the sensing chamber, and wherein the reagent is capable of being reduced by hemoglobin to generate an electrical signal indicative of the presence or absence of hemoglobin, the method including forming an aperture extending through a sheet of electrically resistive material, the aperture defining a side wall of the sensing chamber; mounting a first layer having a first electrode to a first side of the sheet and extending over the aperture whereby to define a first sensing chamber end wall, the first electrode facing the first side of the sheet; mounting a second layer having a second electrode to a second side of the sheet and extending over the aperture whereby to define a second sensing chamber end wall in substantial overlying registration with the first layer, the second electrode facing the second side of the sheet, whereby the sheet and layers form a strip; providing an aperture in the strip to permit entry of sample into the sensing chamber; and providing a reagent capable of being reduced by hemoglobin, wherein the reagent is contained within the sensing chamber. [0021]
  • In one aspect of this embodiment, the method further includes the step of providing a vent in the strip to permit the escape of air displaced from the sensing chamber as sample fills the sensing chamber. [0022]
  • In another aspect of this embodiment, the aperture is of a rectangular cross-section. [0023]
  • In another aspect of this embodiment, at least one of the electrodes includes a noble metal, such as palladium, platinum, and silver. At least one of the electrodes may be a sputter coated metal deposit. The electrodes may be adhered to the sheet, for example, by an adhesive such as a heat activated adhesive, pressure sensitive adhesive, heat cured adhesive, chemically cured adhesive, hot melt adhesive, and hot flow adhesive. [0024]
  • In another aspect of this embodiment, the method may include the step of providing a buffer and/or a red blood cell lysing agent contained within the sensing chamber. The reagent and/or buffer may be printed onto at least one wall of the sensing chamber. A support contained within the sensing chamber may also be provided, such as mesh, fibrous filler, macroporous membrane, sintered powder, or combinations thereof. The reagent may be supported on or contained within the support. [0025]
  • In another aspect of this embodiment, at least the sheet or one of the layers includes a polymeric material selected from polyester, polystyrene, polycarbonate, polyolefin, and mixtures thereof, or polyethylene terephthalate. [0026]
  • In another aspect of this embodiment, the second electrode is mounted in opposing relationship a distance of less than about 500 microns from the first electrode; less than about 150 microns from the first electrode; or less than about 150 microns and greater than about 50 microns from the first electrode. [0027]
  • In another aspect of this embodiment, the electrochemical cell is designed to be disposed of after use in a single experiment.[0028]
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 shows a plan view of an electrochemical cell. [0029]
  • FIG. 2 shows a cross-section view on line [0030] 10-10 of FIG. 1.
  • FIG. 3 shows an end-section view on line [0031] 11-11 of FIG. 1.
  • DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT
  • The following description and examples illustrate a preferred embodiment of the present invention in detail. Those of skill in the art will recognize that there are numerous variations and modifications of this invention that are encompassed by its scope. Accordingly, the description of a preferred embodiment should not be deemed to limit the scope of the present invention. [0032]
  • Other methods and devices for obtaining electrochemical measurements of fluid samples are discussed further in copending U.S. patent application Ser. No. 09/616,433, filed on Jul. 14, 2000, entitled “IMMUNOSENSOR,” copending U.S. patent application Ser. No. 09/615,691, filed on Jul. 14, 2000, entitled “ANTIOXIDANT SENSOR,” copending U.S. patent application Ser. No. 09/616,556, filed on Jul. 14, 2000, entitled “ELECTROCHEMICAL METHOD FOR MEASURING CHEMICAL REACTION RATES,” each of which is incorporated herein by reference in its entirety. [0033]
  • The Sample [0034]
  • In preferred embodiments, a method and device for measuring hemoglobin levels in a fluid whole blood sample is provided. If the whole blood sample is not in liquid form, i.e., dried blood, it can be analyzed after solid sample is mixed into a suitable fluid, e.g., water. Whole blood contained within a solid tissue sample may be analyzed after extraction using techniques well-known in the art. [0035]
  • Prior to its analysis, hemoglobin must be released from the red blood cells in which it is contained. This may be accomplished by pretreating the whole blood sample with a lysing agent prior to its introduction into the electrochemical cell. Alternatively, a lysing agent may be contained within the electrochemical cell itself. Other agents may also be used to pretreat the sample. For example, pH may be adjusted to a desired level by means of a buffer or neutralizing agent, or a substance that renders interfering species nonreactive may be added. [0036]
  • The Electrochemical Cell [0037]
  • The electrochemical cell of the present invention is disposable and designed for use in a single experiment. In a preferred embodiment, the electrochemical cell is a thin layer sensor such as that disclosed in U.S. Pat. No. 5,942,102 (incorporated herein by reference in its entirety). As herein used, the term “thin layer electrochemical cell” refers to a cell having closely spaced electrodes such that reaction products from the counter electrode arrive at the working electrode. In practice, the separation of electrodes in such a cell for measuring glucose in blood will be less than 500 microns, and preferably less than 200 microns. A preferred embodiment of such an electrochemical cell is illustrated in FIGS. 1, 2, and [0038] 3. The cell illustrated in FIGS. 1, 2, and 3 includes a polyester core 4 having a circular aperture 8. Aperture 8 defines a cylindrical cell side wall 12. Adhered to one side of core 4 is a polyester sheet 1 having a sputter coating of palladium 2. The sheet is adhered by means of an adhesive 3 to core 4 with palladium 2 adjacent core 4 and covering aperture 8. A second polyester sheet 7 having a second sputter coating of palladium 6 is adhered by means of contact adhesive 5 to the other side of core 4 and covering aperture 8. There is thereby defined a cell having cylindrical side wall 12 closed on each end by palladium metal 2, 6. The assembly is notched at 9 to provide for a solution to be admitted to the cell or to be drawn in by wicking or capillary action and to allow air to escape. The metal films 2, 6 are connected with suitable electrical connections or formations whereby potentials may be applied and currently measured.
  • Such a thin layer electrochemical cell is prepared by first forming an aperture extending through a sheet of electrically resistive material, the aperture defining a side wall of the electrochemical cell. Suitable electrically resistive materials, which may be used in the sheet containing the aperture, or in other layers in the cell, include, for example, materials such as polyesters, polystyrenes, polycarbonates, polyolefins, polyethylene terephthalate, mixtures thereof, and the like. In a preferred embodiment, the aperture in the sheet is rectangular, however other shapes, e.g., circular, may be used as well. [0039]
  • After the aperture is formed, a first thin electrode layer is then mounted on one side of the sheet of electrically resistive material, extending over the aperture and forming an end wall. The layer may be adhered to the sheet, for example, by means of an adhesive. Suitable adhesives include, for example, heat activated adhesives, pressure sensitive adhesives, heat cured adhesives, chemically cured adhesives, hot melt adhesives, hot flow adhesives, and the like. The electrode layer is prepared by coating (e.g., by sputter coating) a sheet of electrically resistive material with a suitable metal, for example, palladium. [0040]
  • A second thin electrode layer is then mounted on the opposite side of the electrically resistive material, also extending over the aperture, so as to form a second end wall. In a preferred embodiment, the electrode layers are mounted in opposing relationship at a distance of less than about 1 millimeter, desirably less than about 800 microns, more desirably less that about 600, or preferably less than about 500 microns, more preferably less than about 300 to 150 microns, more preferably less than 150 microns, and most preferably between 25, 40, 50, 100 and 150 microns. A second aperture or ingress is then provided for liquid to enter the cell. Such an ingress can be provided by forming a notch along one edge of the device which extends through the electrode layers and aperture. The electrode layers are provided with connection means allowing the sensors to be placed in a measuring circuit. [0041]
  • Chemicals for use in the cell, such as redox reagents, lysing agents, buffers, and other substances, may be supported on the cell electrodes or walls, on one or more independent supports contained within cell, or may be self supporting. If the chemicals are to be supported on the cell electrodes or walls, the chemicals may be applied by use of application techniques well known in the art, such as ink jet printing, screen printing, lithography, ultrasonic spraying, slot coating, gravure printing, and the like. Suitable independent supports may include, but are not limited to, meshes, nonwoven sheets, fibrous fillers, macroporous membranes, and sintered powders. The chemicals for use in the cell may be supported on or contained within a support. [0042]
  • In a preferred embodiment, the materials used within the cell as well as the materials used to construct the cell are in a form amenable to mass production, and the cells themselves are designed to be able to be used for a single experiment then disposed of. [0043]
  • According to the present invention a disposable cell is one that is inexpensive enough to produce that it is economically acceptable to be used only for a single test. Secondly, that the cell may conveniently only be used for a single test. Inconveniently in this context means that steps such as washing and/or reloading of reagents would need to be taken to process the cell after a single use to render it suitable for a subsequent use. [0044]
  • Economically acceptable in this context means that the perceived value of the result of the test to the user is the same or greater than the cost of the cell to purchase and use, the cell purchase price being set by the cost of supplying the cell to the user plus an appropriate mark up. For many applications, this requires that the cells have relatively low materials costs and simple fabrication processes. For example, the electrode materials of the cells should be inexpensive, such as carbon, or be used in sufficiently small amounts such that expensive materials may be used. Screen printing carbon or silver ink is a process suitable for forming electrodes with relatively inexpensive materials. However, if it is desired to use electrode materials such as platinum, palladium, gold or iridium, methods with better material utilization, such as sputtering or evaporative vapor coating, are more suitable as they may give extremely thin films. The substrate materials for the disposable cells also need to be inexpensive. Examples of such inexpensive materials are polymers such as polyvinylchloride, polyimide, polyester and coated papers and cardboard. [0045]
  • Cell assembly methods also need to be amenable to mass production. These methods include fabricating multiple cells on cards and separating the card into individual strips subsequent to the main assembly steps, and web fabrication where the cells are produced on a continuous web, which is subsequently separated into individual strips. Card processes are most suitable when close spatial registration of multiple features is required for the fabrication and/or when stiff cell substrate materials are to be used. Web processes are most suitable when the down web registration of features is not as critical and flexible webs may be used. [0046]
  • The convenient single use requirement for the disposable cell is desirable so that users are not tempted to try to reuse the cell and possibly obtain an inaccurate test result. The single use requirement for the cell may be stated in user instructions accompanying the cell. More preferably, the cell may also be fabricated such that using the cell more than once is difficult or not possible. This may be accomplished, for example, by including reagents that are washed away or consumed during the first test and so are not functional in a second test. Alternatively, the signal of the test may be examined for indications that reagents in the cell have already reacted, such as an abnormally high initial signal, and the test aborted. Another method includes providing a means for breaking electrical connections in the cell after the first test in a cell has been completed. [0047]
  • The Electrodes [0048]
  • At least one of the electrodes in the cell is a sensing electrode, defined as an electrode sensitive to the amount of oxidized redox agent. In the case of a potentiometric sensor wherein the potential of the sensing electrode is indicative of the level of hemoglobin present, a second electrode acting as reference electrode is present which acts to provide a reference potential. [0049]
  • In the case of an amperometric sensor wherein the sensing electrode current is indicative of the level of hemoglobin in the sample, at least one other electrode is present which functions as a counter electrode to complete the electrical circuit. This second electrode may also function as a reference electrode. Alternatively, a separate electrode may perform the function of a reference electrode. [0050]
  • Materials suitable for the sensing, counter, and reference electrodes must be compatible with the redox reagents present in the device. Compatible materials will not react chemically with the redox reagent or any other substance present in the cell. Examples of such suitable materials include, but are not limited to, platinum, palladium, carbon, indium oxide, tin oxide, mixed indium/tin oxides, gold, silver, iridium and mixtures thereof. These materials may be formed into electrode structures by any suitable method, for example, by sputtering, vapor coating, screen printing, thermal evaporation or lithography. In preferred embodiments, the material is sputtered or screen printed to form the electrode structures. [0051]
  • Non-limiting examples of materials suitable for use in the reference electrode include metal/metal salt systems such as silver in contact with silver chloride, silver bromide or silver iodide, and mercury in contact mercurous chloride or mercurous sulfate. The metal may be deposited by any suitable method and then brought into contact with the appropriate metal salt. Suitable methods include, for example, electrolysis in a suitable salt solution or chemical oxidation. Such metal/metal salt systems provide better potential control in potentiometric measurement methods than do single metal component systems. In a preferred embodiment, the metal/metal salt electrode systems are used as a separate reference electrode in an amperometric sensor. [0052]
  • The Lysing Agent [0053]
  • Suitable red blood cell lysing agents include detergents, both ionic and non-ionic, proteolytic enzymes, and lipases. Suitable ionic detergents include, for example, sodium dodecyl sulfate and cetyl trimethylammonium bromide. Non-limiting examples of proteolytic enzymes include trypsin, chymotrypsin, pepsin, papain, and Pronase E, a very active enzyme having broad specificity. Nonionic surfactants suitable for use include, e.g., ethoxylated octylphenols, including the Triton X Series available from Rohm & Haas of Philadelphia, Pa. In a preferred embodiment, saponins, i.e., plant glycosides that foam in water, are used as the lysing agent. [0054]
  • The Redox Reagent [0055]
  • Suitable redox reagents include those which are capable of oxidizing hemoglobin. Examples of redox reagents suitable for use in analyzing hemoglobin include, but are not limited, to salts of ferricyanide, dichromate, vanadium oxides, permanganate, and electroactive organometallic complexes. Organic redox reagents such as dichlorophenolindophenol, and quinones are also suitable. In a preferred embodiment, the redox reagent for analyzing hemoglobin is ferricyanide. [0056]
  • The Buffer [0057]
  • Optionally, a buffer may be present along with the redox reagent in dried form in the electrochemical cell. If a buffer is used, it is present in an amount such that the resulting pH level is suitable for adjusting the oxidizing potential of the redox reagent to a level suitable for oxidizing hemoglobin but not other species that it is not desired to detect. The buffer is present in a sufficient amount so as to substantially maintain the pH of the sample at the desired level during the test. Examples of buffers suitable for use include phosphates, carbonates, alkali metal salts of mellitic acid, and alkali metal salts of citric acid. The choice of buffer will depend on the desired pH. The buffer is selected so as not to react with the redox reagent. [0058]
  • Other Substances Present Within the Cell [0059]
  • In addition to redox reagents and buffers, other substances may also be present within the electrochemical cell. Such substances include, for example, viscosity enhancers and low molecular weight polymers. Hydrophilic substances may also be contained within the cell, such as polyethylene glycol, polyacrylic acid, dextran, and surfactants such as those marketed by Rohm & Haas Company of Philadelphia, Pa., under the trade name Triton™ or by ICI Americas Inc. of Wilmington, Del., under the trade name Tween™. Such substances may enhance the fill rate of the cell, provide a more stable measurement, and inhibit evaporation in small volume samples. [0060]
  • Method for Measuring Hemoglobin Concentration [0061]
  • In measuring hemoglobin present in a whole blood sample, the sample is introduced into the sensor cell, whereupon the sample dissolves the dried reagents and other substances present in the sensor cell. If the sample has not been pretreated with a lysing agent, a lysing agent present in the sensor cell releases hemoglobin from the red blood cells. The redox reagent then reacts with hemoglobin present in the sample to form the reduced form of the redox reagent. In the case of a potentiometric sensor, the resulting ratio of oxidized to reduced form of the redox reagent fixes the potential of the sensing electrode relative to the reference electrode. This potential is then used as a measure of the concentration of the hemoglobin originally in the sample. [0062]
  • In a preferred embodiment, the sensing cell is operated as an amperometric sensor. According to this embodiment, the reduced redox reagent formed by reaction with hemoglobin is electrochemically oxidized at the sensing electrode. The current resulting from this electrochemical reaction is then used to measure the concentration of hemoglobin originally in the sample. In other embodiments, the sensor is operated in potentiometric or coulometric mode. [0063]
  • The cell's electrodes are used to produce an electrical signal, i.e., a voltage or current, readable by an attached meter. In a preferred embodiment, an interface for connecting the cell to the meter is provided. The meter may display the measurement in a visual, audio or other form, or may store the measurement in electronic form. [0064]
  • In a preferred embodiment where ferricyanide is used as the reagent, a typical concentration of hemoglobin, e.g., 14 g/dL, would yield a ferrocyanide concentration of 8.2 mM upon oxidation. The minimum detectable limit in a preferred embodiment of the method and device is approximately 0.1 mM. [0065]
  • Measuring Hemoglobin Using First and Second Potential Application Steps [0066]
  • In a preferred embodiment, substantially complete lysis of all red blood cells is achieved before measurement of hemoglobin. However, a rapid hemoglobin measurement may be obtained even if the lysis step proceeds slowly by using a first and second potential application step. [0067]
  • In such an embodiment, a sensor configuration as described above is used, e.g., a sensor wherein the bottom electrode is palladium, upon which the dried reagents are deposited, and wherein the top electrode is a gold electrode. The first potential is applied by applying a −0.3 V potential at zero time to set the gold electrode as the working electrode. As the red blood cells begin to lyse and the ferricyanide reacts with released hemoglobin, the current will slowly increase. The increase in current can be used in a number of ways: to assess the time required for full lysis and reaction, to extrapolate the signal to longer times, or to assess the fraction of hemoglobin reacted at a given time. The first method gives some quality assurance, and the second and third methods yield a shorter test. [0068]
  • After the first potential has been applied and current has been measured, the potential can be reversed to +0.3 V and the reverse transient current can be measured and analyzed using electrochemical methods known in the art, e.g., as disclosed in U.S. application Ser. No. 08/981385 filed Apr. 17, 1998, and U.S. Pat. No. 5,942,102 (both incorporated herein by reference in their entirety), to calculate the diffusion coefficient and concentration of ferrocyanide. [0069]
  • The first potential application may also be used to subtract interferents. The ferricyanide reacts more quickly with interfering substances which are free in the plasma than with hemoglobin which is packaged in red blood cells. The ratio of the minimum to maximum (or extrapolated) currents resulting from the first potential application may be used to yield the concentration of reduced mediator measured by the second potential pulse (at +0.3 V), thereby yielding a more accurate, corrected concentration of hemoglobin. The simplest correction would be:[0070]
  • [Hb]′=[Hb]*(1−imin/imax)
  • wherein [Hb]′ is the corrected concentration of hemoglobin, [Hb] is the uncorrected concentration of hemoglobin, imin is the measured current and imax is the extrapolated current resulting from the first potential application. [0071]
  • The above description discloses several methods and materials of the present invention. This invention is susceptible to modifications in the methods and materials, as well as alterations in the fabrication methods and equipment. Such modifications will become apparent to those skilled in the art from a consideration of this disclosure or practice of the invention disclosed herein. Consequently, it is not intended that this invention be limited to the specific embodiments disclosed herein, but that it cover all modifications and alternatives coming within the true scope and spirit of the invention as embodied in the attached claims. [0072]

Claims (33)

What is claimed is:
1. A device for measuring an amount of hemoglobin in a sample, the device comprising an electrochemical cell having a sensing chamber, a first electrode, a second electrode wherein the second electrode is a distance of less than about 500 microns from the first electrode, an aperture for admitting the sample into the sensing chamber, and a reagent contained within the sensing chamber wherein the reagent is capable of being reduced by hemoglobin to generate an electrical signal indicative of the amount of hemoglobin.
2. The device of claim 1, wherein the device may only be used for a single test.
3. The device of claim 1, wherein the first electrode comprises a sensing electrode.
4. The device of claim 1, wherein the first electrode comprises a material selected from the group consisting of platinum, palladium, carbon, indium oxide, tin oxide, gold, iridium, copper, steel, silver, and mixtures thereof.
5. The device of claim 1, wherein the first electrode is formed by a technique selected from the group consisting of sputtering, vapor coating, screen printing, thermal evaporation, ink jet printing, ultrasonic spraying, slot coating, gravure printing and lithography.
6. The device of claim 1, wherein the second electrode comprises a counter electrode.
7. The device of claim 1, wherein the second electrode comprises a metal in contact with a metal salt.
8. The device of claim 7, wherein the metal in contact with a metal salt is selected from the group consisting of silver in contact with silver chloride, silver in contact with silver bromide, silver in contact with silver iodide, mercury in contact with mercurous chloride, and mercury in contact with mercurous sulfate.
9. The device of claim 7, the electrochemical cell further comprising a third electrode.
10. The device of claim 9, wherein the third electrode comprises a reference electrode.
11. The device of claim 10, wherein the third electrode comprises a metal in contact with a metal salt.
12. The device of claim 11, wherein the metal in contact with the metal salt is selected from the group consisting of silver in contact with silver chloride, silver in contact with silver bromide, silver in contact with silver iodide, mercury in contact with mercurous chloride, and mercury in contact with mercurous sulfate.
13. The device of claim 1, wherein the second electrode comprises a reference electrode.
14. The device of claim 1, wherein the reagent is selected from the group consisting of dichromate, vanadium oxides, permanganate, electroactive organometallic complexes, quinones, and dichlorophenolindophenol.
15. The device of claim 1, wherein the reagent comprises ferricyanide.
16. The device of claim 1, the sensing chamber further comprising a buffer, wherein the buffer is contained within the sensing chamber.
17. The device of claim 16, wherein the buffer is selected from the group consisting of phosphates, carbonates, alkali metal salts of mellitic acid, and alkali metal salts of citric acid.
18. The device of claim 1, further comprising a red blood cell lysing agent.
19. The device of claim 18, wherein the lysing agent is selected from the group consisting of ionic detergents, nonionic detergents, proteolytic enzymes, and lipases.
20. The device of claim 18, wherein the lysing agent comprises saponin.
21. The device of claim 18, wherein the lysing agent is selected from the group consisting of sodium dodecyl sulfate, cetyl trimethylammonium bromide, and polyethoxylated octylphenol.
22. The device of claim 1, wherein the sample comprises fluid whole blood.
23. The device of claim 1, the sensing chamber further comprising a support, the support contained within the sensing chamber.
24. The device of claim 23, wherein the support is a material selected from the group consisting of mesh, nonwoven sheet, fibrous filler, macroporous membrane, sintered powder, and combinations thereof.
25. The device of claim 23, wherein the reagent is contained within or supported on the support.
26. The device of claim 23, further comprising a buffer, wherein the buffer is contained within or supported on the support.
27. The device of claim 23, wherein the lysing agent is contained within or supported on the support.
28. The device of claim 1, wherein the second electrode is mounted in opposing relationship to the first electrode.
29. The device of claim 1, wherein the second electrode is at a distance of less than about 150 microns from the first electrode.
30. The device according to claim 1, wherein the second electrode is at a distance of from about 50 microns to about 150 microns from the first electrode.
31. The device of claim 1, further comprising an interface for communication with a meter.
32. The device of claim 31, wherein the interface communicates a voltage or a current.
33. The device of claim 1, wherein the electrochemical cell comprises a thin layer electrochemical cell.
US10/443,269 1996-11-15 2003-05-21 Hemoglobin sensor Abandoned US20030201177A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US10/443,269 US20030201177A1 (en) 1996-11-15 2003-05-21 Hemoglobin sensor

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
PCT/AU1996/000723 WO1997018465A1 (en) 1995-11-16 1996-11-15 Electrochemical method
AUPCT/AU96/00724 1996-11-15
PCT/AU1996/000724 WO1997018464A1 (en) 1995-11-16 1996-11-15 Electrochemical cell
US09/068,828 US6179979B1 (en) 1995-11-16 1996-11-15 Electrochemical cell
USPCTAU9600723 1996-11-15
US08/852,804 US5942102A (en) 1995-11-16 1997-05-07 Electrochemical method
US09/314,251 US6174420B1 (en) 1996-11-15 1999-05-18 Electrochemical cell
US09/616,512 US6632349B1 (en) 1996-11-15 2000-07-14 Hemoglobin sensor
US10/443,269 US20030201177A1 (en) 1996-11-15 2003-05-21 Hemoglobin sensor

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US09/616,512 Continuation US6632349B1 (en) 1996-11-15 2000-07-14 Hemoglobin sensor

Publications (1)

Publication Number Publication Date
US20030201177A1 true US20030201177A1 (en) 2003-10-30

Family

ID=28794859

Family Applications (2)

Application Number Title Priority Date Filing Date
US09/616,512 Expired - Lifetime US6632349B1 (en) 1996-11-15 2000-07-14 Hemoglobin sensor
US10/443,269 Abandoned US20030201177A1 (en) 1996-11-15 2003-05-21 Hemoglobin sensor

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US09/616,512 Expired - Lifetime US6632349B1 (en) 1996-11-15 2000-07-14 Hemoglobin sensor

Country Status (1)

Country Link
US (2) US6632349B1 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060228803A1 (en) * 2005-04-08 2006-10-12 Ryan Wayne L Cellular controls for glycated hemoglobin Hb A1c
US20120247956A1 (en) * 2011-04-01 2012-10-04 Taidoc Technology Corpora Biosensor strip and manufacturing method thereof
EP2568281A1 (en) 2011-09-12 2013-03-13 Nova Biomedical Corporation Disposable sensor for electrochemical detection of hemoglobin
WO2015184465A1 (en) * 2014-05-30 2015-12-03 The Regents Of The University Of California Strip-based electrochemical sensors for quantitative analysis of analytes
US9658181B2 (en) 2013-03-14 2017-05-23 Instrumentation Laboratory Company Whole blood hemolysis sensor
US11471092B2 (en) * 2016-06-20 2022-10-18 Greenville Neuromodulation Center Microelectrode with hemoglobin or iron sensor and methods of guiding same

Families Citing this family (93)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69809391T2 (en) 1997-02-06 2003-07-10 Therasense Inc SMALL VOLUME SENSOR FOR IN-VITRO DETERMINATION
US8071384B2 (en) 1997-12-22 2011-12-06 Roche Diagnostics Operations, Inc. Control and calibration solutions and methods for their use
US6391005B1 (en) 1998-03-30 2002-05-21 Agilent Technologies, Inc. Apparatus and method for penetration with shaft having a sensor for sensing penetration depth
US6338790B1 (en) 1998-10-08 2002-01-15 Therasense, Inc. Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator
US20050103624A1 (en) 1999-10-04 2005-05-19 Bhullar Raghbir S. Biosensor and method of making
CN1632553A (en) 1999-11-15 2005-06-29 松下电器产业株式会社 Biosensor, method of forming thin-film electrode, and method and apparatus for quantitative determination
RU2278612C2 (en) * 2000-07-14 2006-06-27 Лайфскен, Инк. Immune sensor
US8641644B2 (en) 2000-11-21 2014-02-04 Sanofi-Aventis Deutschland Gmbh Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means
US9427532B2 (en) 2001-06-12 2016-08-30 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US7025774B2 (en) 2001-06-12 2006-04-11 Pelikan Technologies, Inc. Tissue penetration device
ATE485766T1 (en) 2001-06-12 2010-11-15 Pelikan Technologies Inc ELECTRICAL ACTUATING ELEMENT FOR A LANCET
US8337419B2 (en) 2002-04-19 2012-12-25 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US9226699B2 (en) 2002-04-19 2016-01-05 Sanofi-Aventis Deutschland Gmbh Body fluid sampling module with a continuous compression tissue interface surface
DE60234598D1 (en) 2001-06-12 2010-01-14 Pelikan Technologies Inc SELF-OPTIMIZING LANZET DEVICE WITH ADAPTANT FOR TEMPORAL FLUCTUATIONS OF SKIN PROPERTIES
US7749174B2 (en) 2001-06-12 2010-07-06 Pelikan Technologies, Inc. Method and apparatus for lancet launching device intergrated onto a blood-sampling cartridge
US7981056B2 (en) 2002-04-19 2011-07-19 Pelikan Technologies, Inc. Methods and apparatus for lancet actuation
US9795747B2 (en) 2010-06-02 2017-10-24 Sanofi-Aventis Deutschland Gmbh Methods and apparatus for lancet actuation
US20060134713A1 (en) * 2002-03-21 2006-06-22 Lifescan, Inc. Biosensor apparatus and methods of use
US20030180814A1 (en) * 2002-03-21 2003-09-25 Alastair Hodges Direct immunosensor assay
US8360992B2 (en) 2002-04-19 2013-01-29 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7232451B2 (en) 2002-04-19 2007-06-19 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US9795334B2 (en) 2002-04-19 2017-10-24 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7331931B2 (en) 2002-04-19 2008-02-19 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7976476B2 (en) 2002-04-19 2011-07-12 Pelikan Technologies, Inc. Device and method for variable speed lancet
US8784335B2 (en) 2002-04-19 2014-07-22 Sanofi-Aventis Deutschland Gmbh Body fluid sampling device with a capacitive sensor
US7297122B2 (en) 2002-04-19 2007-11-20 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7909778B2 (en) 2002-04-19 2011-03-22 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7175642B2 (en) 2002-04-19 2007-02-13 Pelikan Technologies, Inc. Methods and apparatus for lancet actuation
US7547287B2 (en) 2002-04-19 2009-06-16 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8267870B2 (en) 2002-04-19 2012-09-18 Sanofi-Aventis Deutschland Gmbh Method and apparatus for body fluid sampling with hybrid actuation
US7226461B2 (en) 2002-04-19 2007-06-05 Pelikan Technologies, Inc. Method and apparatus for a multi-use body fluid sampling device with sterility barrier release
US7901362B2 (en) 2002-04-19 2011-03-08 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7892185B2 (en) 2002-04-19 2011-02-22 Pelikan Technologies, Inc. Method and apparatus for body fluid sampling and analyte sensing
US7229458B2 (en) 2002-04-19 2007-06-12 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US9314194B2 (en) 2002-04-19 2016-04-19 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US7491178B2 (en) 2002-04-19 2009-02-17 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8221334B2 (en) 2002-04-19 2012-07-17 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US9248267B2 (en) 2002-04-19 2016-02-02 Sanofi-Aventis Deustchland Gmbh Tissue penetration device
US8702624B2 (en) 2006-09-29 2014-04-22 Sanofi-Aventis Deutschland Gmbh Analyte measurement device with a single shot actuator
US7892183B2 (en) 2002-04-19 2011-02-22 Pelikan Technologies, Inc. Method and apparatus for body fluid sampling and analyte sensing
US8579831B2 (en) 2002-04-19 2013-11-12 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7674232B2 (en) 2002-04-19 2010-03-09 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7291256B2 (en) * 2002-09-12 2007-11-06 Lifescan, Inc. Mediator stabilized reagent compositions and methods for their use in electrochemical analyte detection assays
US8574895B2 (en) 2002-12-30 2013-11-05 Sanofi-Aventis Deutschland Gmbh Method and apparatus using optical techniques to measure analyte levels
EP1628567B1 (en) 2003-05-30 2010-08-04 Pelikan Technologies Inc. Method and apparatus for fluid injection
DK1633235T3 (en) 2003-06-06 2014-08-18 Sanofi Aventis Deutschland Apparatus for sampling body fluid and detecting analyte
WO2006001797A1 (en) 2004-06-14 2006-01-05 Pelikan Technologies, Inc. Low pain penetrating
US8148164B2 (en) 2003-06-20 2012-04-03 Roche Diagnostics Operations, Inc. System and method for determining the concentration of an analyte in a sample fluid
US8206565B2 (en) 2003-06-20 2012-06-26 Roche Diagnostics Operation, Inc. System and method for coding information on a biosensor test strip
US7718439B2 (en) 2003-06-20 2010-05-18 Roche Diagnostics Operations, Inc. System and method for coding information on a biosensor test strip
US8058077B2 (en) 2003-06-20 2011-11-15 Roche Diagnostics Operations, Inc. Method for coding information on a biosensor test strip
US8679853B2 (en) 2003-06-20 2014-03-25 Roche Diagnostics Operations, Inc. Biosensor with laser-sealed capillary space and method of making
US7488601B2 (en) 2003-06-20 2009-02-10 Roche Diagnostic Operations, Inc. System and method for determining an abused sensor during analyte measurement
US7452457B2 (en) 2003-06-20 2008-11-18 Roche Diagnostics Operations, Inc. System and method for analyte measurement using dose sufficiency electrodes
US7645421B2 (en) 2003-06-20 2010-01-12 Roche Diagnostics Operations, Inc. System and method for coding information on a biosensor test strip
US8071030B2 (en) 2003-06-20 2011-12-06 Roche Diagnostics Operations, Inc. Test strip with flared sample receiving chamber
PT1639352T (en) 2003-06-20 2018-07-09 Hoffmann La Roche Method and reagent for producing narrow, homogenous reagent strips
US7645373B2 (en) 2003-06-20 2010-01-12 Roche Diagnostic Operations, Inc. System and method for coding information on a biosensor test strip
US7999003B2 (en) * 2003-08-26 2011-08-16 Mannatech, Incorporated Antioxidant compositions and methods thereto
US8282576B2 (en) 2003-09-29 2012-10-09 Sanofi-Aventis Deutschland Gmbh Method and apparatus for an improved sample capture device
JP4458802B2 (en) * 2003-10-02 2010-04-28 パナソニック株式会社 Method for measuring glucose in blood and sensor used therefor
EP1680014A4 (en) 2003-10-14 2009-01-21 Pelikan Technologies Inc Method and apparatus for a variable user interface
US8088271B2 (en) * 2003-12-04 2012-01-03 Panasonic Corporation Method of measuring hematocrit (Hct), sensor used in the method, and measuring device
WO2005054840A1 (en) * 2003-12-04 2005-06-16 Matsushita Electric Industrial Co., Ltd. Blood component measuring method, sensor used therefor, and measuring instrument
US7822454B1 (en) 2005-01-03 2010-10-26 Pelikan Technologies, Inc. Fluid sampling device with improved analyte detecting member configuration
EP1706026B1 (en) 2003-12-31 2017-03-01 Sanofi-Aventis Deutschland GmbH Method and apparatus for improving fluidic flow and sample capture
EP1713926B1 (en) 2004-02-06 2012-08-01 Bayer HealthCare, LLC Oxidizable species as an internal reference for biosensors and method of use
CN1938590B (en) * 2004-04-19 2010-05-05 松下电器产业株式会社 Method for measuring blood components and biosensor and measuring instrument for use therein
US8828203B2 (en) 2004-05-20 2014-09-09 Sanofi-Aventis Deutschland Gmbh Printable hydrogels for biosensors
US9775553B2 (en) 2004-06-03 2017-10-03 Sanofi-Aventis Deutschland Gmbh Method and apparatus for a fluid sampling device
EP1765194A4 (en) 2004-06-03 2010-09-29 Pelikan Technologies Inc Method and apparatus for a fluid sampling device
US7569126B2 (en) 2004-06-18 2009-08-04 Roche Diagnostics Operations, Inc. System and method for quality assurance of a biosensor test strip
US8652831B2 (en) 2004-12-30 2014-02-18 Sanofi-Aventis Deutschland Gmbh Method and apparatus for analyte measurement test time
KR101321296B1 (en) 2005-07-20 2013-10-28 바이엘 헬스케어 엘엘씨 Gated amperometry temperature determination
JP5671205B2 (en) 2005-09-30 2015-02-18 バイエル・ヘルスケア・エルエルシー Gated voltammetry
US8163162B2 (en) * 2006-03-31 2012-04-24 Lifescan, Inc. Methods and apparatus for analyzing a sample in the presence of interferents
US20080297169A1 (en) * 2007-05-31 2008-12-04 Greenquist Alfred C Particle Fraction Determination of A Sample
WO2009076302A1 (en) 2007-12-10 2009-06-18 Bayer Healthcare Llc Control markers for auto-detection of control solution and methods of use
WO2009126900A1 (en) 2008-04-11 2009-10-15 Pelikan Technologies, Inc. Method and apparatus for analyte detecting device
TWI401431B (en) * 2008-06-25 2013-07-11 Apex Biotechnology Corp Hemoglobin-detecting electrode test strip and device comprising the same
MX2011003952A (en) * 2008-10-14 2011-05-23 Piramal Healtcare Ltd Non-enzymatic electrochemical method for simultaneous determination of total hemoglobin and glycated hemoglobin.
US9375169B2 (en) 2009-01-30 2016-06-28 Sanofi-Aventis Deutschland Gmbh Cam drive for managing disposable penetrating member actions with a single motor and motor and control system
US8221994B2 (en) 2009-09-30 2012-07-17 Cilag Gmbh International Adhesive composition for use in an immunosensor
US8101065B2 (en) 2009-12-30 2012-01-24 Lifescan, Inc. Systems, devices, and methods for improving accuracy of biosensors using fill time
US8877034B2 (en) 2009-12-30 2014-11-04 Lifescan, Inc. Systems, devices, and methods for measuring whole blood hematocrit based on initial fill velocity
US8965476B2 (en) 2010-04-16 2015-02-24 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US8603323B2 (en) * 2010-09-20 2013-12-10 Lifescan, Inc. Apparatus and process for improved measurements of a monitoring device
US8932445B2 (en) 2010-09-30 2015-01-13 Cilag Gmbh International Systems and methods for improved stability of electrochemical sensors
US8617370B2 (en) 2010-09-30 2013-12-31 Cilag Gmbh International Systems and methods of discriminating between a control sample and a test fluid using capacitance
US9278187B2 (en) 2013-03-13 2016-03-08 Biosense Webster (Israel) Ltd. Method for making a low OHMIC pressure-contact electrical connection between split ring electrode and lead wire
CN105548297A (en) * 2015-12-11 2016-05-04 武汉璟泓万方堂医药科技股份有限公司 Hemoglobin quantitative detection system and detection method based on electrochemical biosensor
US11199551B1 (en) * 2017-11-22 2021-12-14 Jim Connolly Test sensors, systems, and analysis techniques for measuring glycated hemoglobin in undiluted blood samples
CN116609411B (en) * 2023-07-20 2023-10-13 中国科学院烟台海岸带研究所 Method for improving slope sensitivity of solid contact type ion selective electrode and application thereof

Citations (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3552928A (en) * 1967-07-19 1971-01-05 Miles Lab Whole blood separation means and test system using same
US4053381A (en) * 1976-05-19 1977-10-11 Eastman Kodak Company Device for determining ionic activity of components of liquid drops
US4076596A (en) * 1976-10-07 1978-02-28 Leeds & Northrup Company Apparatus for electrolytically determining a species in a fluid and method of use
US4125372A (en) * 1975-04-01 1978-11-14 Kabushiki Kaisha Kyoto Kaiichi Kagaku Method and device for testing liquids
US4168146A (en) * 1975-01-27 1979-09-18 Ab Kabi Immunoassay with test strip having antibodies bound thereto
US4224125A (en) * 1977-09-28 1980-09-23 Matsushita Electric Industrial Co., Ltd. Enzyme electrode
US4225557A (en) * 1977-07-01 1980-09-30 Rohm Gmbh Packaged diagnostic test strip
US4301412A (en) * 1979-10-29 1981-11-17 United States Surgical Corporation Liquid conductivity measuring system and sample cards therefor
US4301414A (en) * 1979-10-29 1981-11-17 United States Surgical Corporation Disposable sample card and method of making same
US4319969A (en) * 1979-08-31 1982-03-16 Asahi Glass Company, Ltd. Aqueous alkali metal chloride electrolytic cell
US4374013A (en) * 1980-03-05 1983-02-15 Enfors Sven Olof Oxygen stabilized enzyme electrode
US4404066A (en) * 1980-08-25 1983-09-13 The Yellow Springs Instrument Company Method for quantitatively determining a particular substrate catalyzed by a multisubstrate enzyme
US4431507A (en) * 1981-01-14 1984-02-14 Matsushita Electric Industrial Co., Ltd. Enzyme electrode
US4431004A (en) * 1981-10-27 1984-02-14 Bessman Samuel P Implantable glucose sensor
US4508613A (en) * 1983-12-19 1985-04-02 Gould Inc. Miniaturized potassium ion sensor
US4508821A (en) * 1983-07-05 1985-04-02 Becton Dickinson And Company Detection of white cell associated bacteria with a fluorescent dye
US4517287A (en) * 1979-04-04 1985-05-14 Boehringer Mannheim Gmbh Method and reagent for the enzymatic determination of enzyme substrates
US4517291A (en) * 1983-08-15 1985-05-14 E. I. Du Pont De Nemours And Company Biological detection process using polymer-coated electrodes
US4533440A (en) * 1983-08-04 1985-08-06 General Electric Company Method for continuous measurement of the sulfite/sulfate ratio
US4545382A (en) * 1981-10-23 1985-10-08 Genetics International, Inc. Sensor for components of a liquid mixture
US4552840A (en) * 1982-12-02 1985-11-12 California And Hawaiian Sugar Company Enzyme electrode and method for dextran analysis
US4604264A (en) * 1982-12-23 1986-08-05 Boehringer Mannheim Gmbh Test strips
US4637978A (en) * 1983-10-28 1987-01-20 Eastman Kodak Company Assay for analysis of whole blood
US4711245A (en) * 1983-05-05 1987-12-08 Genetics International, Inc. Sensor for components of a liquid mixture
US4790979A (en) * 1986-08-29 1988-12-13 Technimed Corporation Test strip and fixture
US4797256A (en) * 1987-06-05 1989-01-10 Boehringer Mannheim Corporation Registration device for blood test strips
US4854197A (en) * 1987-01-20 1989-08-08 Hedley Purvis Limited Torque wrenches
US4859583A (en) * 1985-02-25 1989-08-22 Amoco Corporation Chemiluminescent immunochemical technique for low molecular weight antigens
US4871440A (en) * 1987-07-06 1989-10-03 Daiken Industries, Ltd. Biosensor
US4871258A (en) * 1988-04-29 1989-10-03 Boehringer Mannheim Corporation Color test meter
US4883764A (en) * 1987-07-20 1989-11-28 Kloepfer Mary A Blood test strip
US4897173A (en) * 1985-06-21 1990-01-30 Matsushita Electric Industrial Co., Ltd. Biosensor and method for making the same
US4900424A (en) * 1986-11-28 1990-02-13 Unilever Patent Holdings B.V. Electrochemical measurement cell
US4919770A (en) * 1982-07-30 1990-04-24 Siemens Aktiengesellschaft Method for determining the concentration of electro-chemically convertible substances
US4943522A (en) * 1987-06-01 1990-07-24 Quidel Lateral flow, non-bibulous membrane assay protocols
US4943533A (en) * 1984-03-01 1990-07-24 The Regents Of The University Of California Hybrid cell lines that produce monoclonal antibodies to epidermal growth factor receptor
US4963815A (en) * 1987-07-10 1990-10-16 Molecular Devices Corporation Photoresponsive electrode for determination of redox potential
US4988429A (en) * 1989-06-30 1991-01-29 Dragerwerk Aktiengesellschaft Measuring cell for an electrochemical gas sensor
US4994238A (en) * 1988-06-09 1991-02-19 Daffern George M Constant volume chemical analysis test device
US4999582A (en) * 1989-12-15 1991-03-12 Boehringer Mannheim Corp. Biosensor electrode excitation circuit
US5059908A (en) * 1990-05-31 1991-10-22 Capital Controls Company, Inc. Amperimetric measurement with cell electrode deplating
US5096809A (en) * 1988-07-25 1992-03-17 Pacific Biotech, Inc. Whole blood assays using porous membrane support devices
US5120420A (en) * 1988-03-31 1992-06-09 Matsushita Electric Industrial Co., Ltd. Biosensor and a process for preparation thereof
US5122244A (en) * 1990-02-03 1992-06-16 Boehringer Mannheim Gmbh Method and sensor electrode system for the electrochemical determination of an analyte or an oxidoreductase as well as the use of suitable compounds therefor
US5126015A (en) * 1990-12-12 1992-06-30 James River Corporation Of Virginia Method for simultaneously drying and imprinting moist fibrous webs
US5126034A (en) * 1988-07-21 1992-06-30 Medisense, Inc. Bioelectrochemical electrodes
US5141868A (en) * 1984-06-13 1992-08-25 Internationale Octrooi Maatschappij "Octropa" Bv Device for use in chemical test procedures
US5156972A (en) * 1989-09-05 1992-10-20 The State Of Israel, Atomic Energy Commission, Soreq Nuclear Research Center Analyte specific chemical sensor with a ligand and an analogue bound on the sensing surface
US5179005A (en) * 1986-08-13 1993-01-12 Lifescan, Inc. Minimum procedure system for the determination of analytes
US5185256A (en) * 1985-06-21 1993-02-09 Matsushita Electric Industrial Co., Ltd. Method for making a biosensor
US5192415A (en) * 1991-03-04 1993-03-09 Matsushita Electric Industrial Co., Ltd. Biosensor utilizing enzyme and a method for producing the same
US5229282A (en) * 1989-11-24 1993-07-20 Matsushita Electric Industrial Co., Ltd. Preparation of biosensor having a layer containing an enzyme, electron acceptor and hydrophilic polymer on an electrode system
US5239258A (en) * 1992-04-03 1993-08-24 University Of Dayton Freshness and stability test using oxidative degradation
US5243516A (en) * 1989-12-15 1993-09-07 Boehringer Mannheim Corporation Biosensing instrument and method
US5268890A (en) * 1993-02-09 1993-12-07 Delco Electronics Corporation Self-cleaning optical disc system
US5272087A (en) * 1988-04-20 1993-12-21 Centre National De La Recherche Scientifique (C.N.R.S.) Enzymatic electrode and its preparation method
US5288387A (en) * 1990-06-12 1994-02-22 Daikin Industries, Ltd. Apparatus for maintaining the activity of an enzyme electrode
US5306623A (en) * 1989-08-28 1994-04-26 Lifescan, Inc. Visual blood glucose concentration test strip
US5312590A (en) * 1989-04-24 1994-05-17 National University Of Singapore Amperometric sensor for single and multicomponent analysis
US5314605A (en) * 1989-06-30 1994-05-24 Dragerwerk Aktiengesellschaft Measuring cell for electrochemically detecting a gas
US5320732A (en) * 1990-07-20 1994-06-14 Matsushita Electric Industrial Co., Ltd. Biosensor and measuring apparatus using the same
US5342498A (en) * 1991-06-26 1994-08-30 Graves Jeffrey A Electronic wiring substrate
US5382346A (en) * 1991-05-17 1995-01-17 Kyoto Daiichi Kagaku Co., Ltd. Biosensor and method of quantitative analysis using the same
US5384028A (en) * 1992-08-28 1995-01-24 Nec Corporation Biosensor with a data memory
US5385846A (en) * 1993-06-03 1995-01-31 Boehringer Mannheim Corporation Biosensor and method for hematocrit determination
US5393399A (en) * 1992-09-07 1995-02-28 Gie Cylergie Amperometric measuring device having an electrochemical sensor
US5413890A (en) * 1992-10-30 1995-05-09 Nippon Shokubai, Co., Ltd. Toner and method for production thereof
US5418142A (en) * 1989-08-28 1995-05-23 Lifescan, Inc. Glucose test strip for whole blood
US5427912A (en) * 1993-08-27 1995-06-27 Boehringer Mannheim Corporation Electrochemical enzymatic complementation immunoassay
US5437999A (en) * 1994-02-22 1995-08-01 Boehringer Mannheim Corporation Electrochemical sensor
US5508171A (en) * 1989-12-15 1996-04-16 Boehringer Mannheim Corporation Assay method with enzyme electrode system
US5509410A (en) * 1983-06-06 1996-04-23 Medisense, Inc. Strip electrode including screen printing of a single layer
US5518590A (en) * 1994-06-21 1996-05-21 Pennzoil Products Company Electrochemical sensors for motor oils and other lubricants
US5567302A (en) * 1995-06-07 1996-10-22 Molecular Devices Corporation Electrochemical system for rapid detection of biochemical agents that catalyze a redox potential change
US5645709A (en) * 1993-12-08 1997-07-08 Van Den Bergh Foods Co., Division Of Conopco, Inc. Methods and apparatus for electrochemical measurements
US5776324A (en) * 1996-05-17 1998-07-07 Encelle, Inc. Electrochemical biosensors
US5863400A (en) * 1994-04-14 1999-01-26 Usf Filtration & Separations Group Inc. Electrochemical cells
US5942102A (en) * 1995-11-16 1999-08-24 Usf Filtration And Separations Group Inc. Electrochemical method
US5997617A (en) * 1997-01-31 1999-12-07 Healthdyne Technologies, Inc. Pressure swing absorption system with multi-chamber canister
US6054039A (en) * 1997-08-18 2000-04-25 Shieh; Paul Determination of glycoprotein and glycosylated hemoglobin in blood
US6111096A (en) * 1997-10-31 2000-08-29 Bbi Bioseq, Inc. Nucleic acid isolation and purification
US6193865B1 (en) * 1997-09-11 2001-02-27 Usf Filtration And Separations Group, Inc. Analytic cell
US6251260B1 (en) * 1998-08-24 2001-06-26 Therasense, Inc. Potentiometric sensors for analytic determination

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8305704D0 (en) 1983-10-18 1983-10-18 Leo Ab Cuvette
JPS636451A (en) 1986-06-27 1988-01-12 Terumo Corp Enzyme sensor
GB8618022D0 (en) 1986-07-23 1986-08-28 Unilever Plc Electrochemical measurements
GB8619627D0 (en) * 1986-08-12 1986-09-24 Genetics Int Inc Electrochemical assay
EP0278647A3 (en) 1987-02-09 1989-09-20 AT&T Corp. Electronchemical processes involving enzymes
GB2201248B (en) 1987-02-24 1991-04-17 Ici Plc Enzyme electrode sensors
US5128015A (en) 1988-03-15 1992-07-07 Tall Oak Ventures Method and apparatus for amperometric diagnostic analysis
EP0654659B1 (en) 1988-06-09 1997-02-12 Boehringer Mannheim Corporation Defined volume test device
CA1316572C (en) 1988-07-18 1993-04-20 Martin J. Patko Precalibrated, disposable, electrochemical sensors
US5236567A (en) 1989-05-31 1993-08-17 Nakano Vinegar Co., Ltd. Enzyme sensor
DE3922495A1 (en) 1989-07-08 1991-01-17 Miles Inc ANALYSIS METHOD FOR SUBSTANCES FROM BIOLOGICAL FLUIDS, IN PARTICULAR FULLBLOOD
WO1992015701A1 (en) 1991-02-27 1992-09-17 Boehringer Mannheim Corporation Improved method and reagent for determination of an analyte
AU3104293A (en) 1992-01-14 1993-07-15 Commonwealth Scientific And Industrial Research Organisation Viscometer
EP0560336B1 (en) 1992-03-12 1998-05-06 Matsushita Electric Industrial Co., Ltd. A biosensor including a catalyst made from phosphate
GR1002549B (en) 1992-05-12 1997-01-28 Lifescan Inc. Fluid conducting test strip with Transport Medium
FR2701117B1 (en) 1993-02-04 1995-03-10 Asulab Sa Electrochemical measurement system with multizone sensor, and its application to glucose measurement.
US5413690A (en) 1993-07-23 1995-05-09 Boehringer Mannheim Corporation Potentiometric biosensor and the method of its use
GB9402591D0 (en) 1994-02-10 1994-04-06 Univ Cranfield Hexacyanoferrate (III) modified carbon electrodes
US5620579A (en) 1995-05-05 1997-04-15 Bayer Corporation Apparatus for reduction of bias in amperometric sensors
AUPN363995A0 (en) 1995-06-19 1995-07-13 Memtec Limited Electrochemical cell
US5665215A (en) 1995-09-25 1997-09-09 Bayer Corporation Method and apparatus for making predetermined events with a biosensor
US5628890A (en) 1995-09-27 1997-05-13 Medisense, Inc. Electrochemical sensor
AUPO229696A0 (en) 1996-09-13 1996-10-10 Memtec America Corporation Analytic cell
US6224115B1 (en) 1996-10-08 2001-05-01 Delaware Capital Formation, Inc. Bulkhead fitting for underground sump
AUPO581397A0 (en) 1997-03-21 1997-04-17 Memtec America Corporation Sensor connection means
US5997817A (en) 1997-12-05 1999-12-07 Roche Diagnostics Corporation Electrochemical biosensor test strip

Patent Citations (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3552928A (en) * 1967-07-19 1971-01-05 Miles Lab Whole blood separation means and test system using same
US4168146A (en) * 1975-01-27 1979-09-18 Ab Kabi Immunoassay with test strip having antibodies bound thereto
US4125372A (en) * 1975-04-01 1978-11-14 Kabushiki Kaisha Kyoto Kaiichi Kagaku Method and device for testing liquids
US4053381A (en) * 1976-05-19 1977-10-11 Eastman Kodak Company Device for determining ionic activity of components of liquid drops
US4076596A (en) * 1976-10-07 1978-02-28 Leeds & Northrup Company Apparatus for electrolytically determining a species in a fluid and method of use
US4225557A (en) * 1977-07-01 1980-09-30 Rohm Gmbh Packaged diagnostic test strip
US4224125A (en) * 1977-09-28 1980-09-23 Matsushita Electric Industrial Co., Ltd. Enzyme electrode
US4517287A (en) * 1979-04-04 1985-05-14 Boehringer Mannheim Gmbh Method and reagent for the enzymatic determination of enzyme substrates
US4319969A (en) * 1979-08-31 1982-03-16 Asahi Glass Company, Ltd. Aqueous alkali metal chloride electrolytic cell
US4301412A (en) * 1979-10-29 1981-11-17 United States Surgical Corporation Liquid conductivity measuring system and sample cards therefor
US4301414A (en) * 1979-10-29 1981-11-17 United States Surgical Corporation Disposable sample card and method of making same
US4374013A (en) * 1980-03-05 1983-02-15 Enfors Sven Olof Oxygen stabilized enzyme electrode
US4404066A (en) * 1980-08-25 1983-09-13 The Yellow Springs Instrument Company Method for quantitatively determining a particular substrate catalyzed by a multisubstrate enzyme
US4431507A (en) * 1981-01-14 1984-02-14 Matsushita Electric Industrial Co., Ltd. Enzyme electrode
US4545382A (en) * 1981-10-23 1985-10-08 Genetics International, Inc. Sensor for components of a liquid mixture
US4431004A (en) * 1981-10-27 1984-02-14 Bessman Samuel P Implantable glucose sensor
US4919770A (en) * 1982-07-30 1990-04-24 Siemens Aktiengesellschaft Method for determining the concentration of electro-chemically convertible substances
US4552840A (en) * 1982-12-02 1985-11-12 California And Hawaiian Sugar Company Enzyme electrode and method for dextran analysis
US4820489A (en) * 1982-12-23 1989-04-11 Boehringer Mannheim Gmbh Test strips and a process for the production thereof
US4604264A (en) * 1982-12-23 1986-08-05 Boehringer Mannheim Gmbh Test strips
US4711245A (en) * 1983-05-05 1987-12-08 Genetics International, Inc. Sensor for components of a liquid mixture
US5509410A (en) * 1983-06-06 1996-04-23 Medisense, Inc. Strip electrode including screen printing of a single layer
US4508821A (en) * 1983-07-05 1985-04-02 Becton Dickinson And Company Detection of white cell associated bacteria with a fluorescent dye
US4533440A (en) * 1983-08-04 1985-08-06 General Electric Company Method for continuous measurement of the sulfite/sulfate ratio
US4517291A (en) * 1983-08-15 1985-05-14 E. I. Du Pont De Nemours And Company Biological detection process using polymer-coated electrodes
US4637978A (en) * 1983-10-28 1987-01-20 Eastman Kodak Company Assay for analysis of whole blood
US4508613A (en) * 1983-12-19 1985-04-02 Gould Inc. Miniaturized potassium ion sensor
US4943533A (en) * 1984-03-01 1990-07-24 The Regents Of The University Of California Hybrid cell lines that produce monoclonal antibodies to epidermal growth factor receptor
US5141868A (en) * 1984-06-13 1992-08-25 Internationale Octrooi Maatschappij "Octropa" Bv Device for use in chemical test procedures
US4859583A (en) * 1985-02-25 1989-08-22 Amoco Corporation Chemiluminescent immunochemical technique for low molecular weight antigens
US5185256A (en) * 1985-06-21 1993-02-09 Matsushita Electric Industrial Co., Ltd. Method for making a biosensor
US4897173A (en) * 1985-06-21 1990-01-30 Matsushita Electric Industrial Co., Ltd. Biosensor and method for making the same
US5179005A (en) * 1986-08-13 1993-01-12 Lifescan, Inc. Minimum procedure system for the determination of analytes
US4790979A (en) * 1986-08-29 1988-12-13 Technimed Corporation Test strip and fixture
US4900424A (en) * 1986-11-28 1990-02-13 Unilever Patent Holdings B.V. Electrochemical measurement cell
US4854197A (en) * 1987-01-20 1989-08-08 Hedley Purvis Limited Torque wrenches
US4943522A (en) * 1987-06-01 1990-07-24 Quidel Lateral flow, non-bibulous membrane assay protocols
US4797256A (en) * 1987-06-05 1989-01-10 Boehringer Mannheim Corporation Registration device for blood test strips
US4871440A (en) * 1987-07-06 1989-10-03 Daiken Industries, Ltd. Biosensor
US4963815A (en) * 1987-07-10 1990-10-16 Molecular Devices Corporation Photoresponsive electrode for determination of redox potential
US4883764A (en) * 1987-07-20 1989-11-28 Kloepfer Mary A Blood test strip
US5120420A (en) * 1988-03-31 1992-06-09 Matsushita Electric Industrial Co., Ltd. Biosensor and a process for preparation thereof
US5120420B1 (en) * 1988-03-31 1999-11-09 Matsushita Electric Ind Co Ltd Biosensor and a process for preparation thereof
US5272087A (en) * 1988-04-20 1993-12-21 Centre National De La Recherche Scientifique (C.N.R.S.) Enzymatic electrode and its preparation method
US4871258A (en) * 1988-04-29 1989-10-03 Boehringer Mannheim Corporation Color test meter
US4994238A (en) * 1988-06-09 1991-02-19 Daffern George M Constant volume chemical analysis test device
US5126034A (en) * 1988-07-21 1992-06-30 Medisense, Inc. Bioelectrochemical electrodes
US5096809A (en) * 1988-07-25 1992-03-17 Pacific Biotech, Inc. Whole blood assays using porous membrane support devices
US5312590A (en) * 1989-04-24 1994-05-17 National University Of Singapore Amperometric sensor for single and multicomponent analysis
US4988429A (en) * 1989-06-30 1991-01-29 Dragerwerk Aktiengesellschaft Measuring cell for an electrochemical gas sensor
US5314605A (en) * 1989-06-30 1994-05-24 Dragerwerk Aktiengesellschaft Measuring cell for electrochemically detecting a gas
US5418142A (en) * 1989-08-28 1995-05-23 Lifescan, Inc. Glucose test strip for whole blood
US5306623A (en) * 1989-08-28 1994-04-26 Lifescan, Inc. Visual blood glucose concentration test strip
US5156972A (en) * 1989-09-05 1992-10-20 The State Of Israel, Atomic Energy Commission, Soreq Nuclear Research Center Analyte specific chemical sensor with a ligand and an analogue bound on the sensing surface
US5229282A (en) * 1989-11-24 1993-07-20 Matsushita Electric Industrial Co., Ltd. Preparation of biosensor having a layer containing an enzyme, electron acceptor and hydrophilic polymer on an electrode system
US5243516A (en) * 1989-12-15 1993-09-07 Boehringer Mannheim Corporation Biosensing instrument and method
US5508171A (en) * 1989-12-15 1996-04-16 Boehringer Mannheim Corporation Assay method with enzyme electrode system
US4999582A (en) * 1989-12-15 1991-03-12 Boehringer Mannheim Corp. Biosensor electrode excitation circuit
US5122244A (en) * 1990-02-03 1992-06-16 Boehringer Mannheim Gmbh Method and sensor electrode system for the electrochemical determination of an analyte or an oxidoreductase as well as the use of suitable compounds therefor
US5059908A (en) * 1990-05-31 1991-10-22 Capital Controls Company, Inc. Amperimetric measurement with cell electrode deplating
US5288387A (en) * 1990-06-12 1994-02-22 Daikin Industries, Ltd. Apparatus for maintaining the activity of an enzyme electrode
US5320732A (en) * 1990-07-20 1994-06-14 Matsushita Electric Industrial Co., Ltd. Biosensor and measuring apparatus using the same
US5126015A (en) * 1990-12-12 1992-06-30 James River Corporation Of Virginia Method for simultaneously drying and imprinting moist fibrous webs
US5192415A (en) * 1991-03-04 1993-03-09 Matsushita Electric Industrial Co., Ltd. Biosensor utilizing enzyme and a method for producing the same
US5382346A (en) * 1991-05-17 1995-01-17 Kyoto Daiichi Kagaku Co., Ltd. Biosensor and method of quantitative analysis using the same
US5342498A (en) * 1991-06-26 1994-08-30 Graves Jeffrey A Electronic wiring substrate
US5239258A (en) * 1992-04-03 1993-08-24 University Of Dayton Freshness and stability test using oxidative degradation
US5384028A (en) * 1992-08-28 1995-01-24 Nec Corporation Biosensor with a data memory
US5393399A (en) * 1992-09-07 1995-02-28 Gie Cylergie Amperometric measuring device having an electrochemical sensor
US5413890A (en) * 1992-10-30 1995-05-09 Nippon Shokubai, Co., Ltd. Toner and method for production thereof
US5268890A (en) * 1993-02-09 1993-12-07 Delco Electronics Corporation Self-cleaning optical disc system
US5385846A (en) * 1993-06-03 1995-01-31 Boehringer Mannheim Corporation Biosensor and method for hematocrit determination
US5427912A (en) * 1993-08-27 1995-06-27 Boehringer Mannheim Corporation Electrochemical enzymatic complementation immunoassay
US5645709A (en) * 1993-12-08 1997-07-08 Van Den Bergh Foods Co., Division Of Conopco, Inc. Methods and apparatus for electrochemical measurements
US5437999A (en) * 1994-02-22 1995-08-01 Boehringer Mannheim Corporation Electrochemical sensor
US5863400A (en) * 1994-04-14 1999-01-26 Usf Filtration & Separations Group Inc. Electrochemical cells
US5518590A (en) * 1994-06-21 1996-05-21 Pennzoil Products Company Electrochemical sensors for motor oils and other lubricants
US5567302A (en) * 1995-06-07 1996-10-22 Molecular Devices Corporation Electrochemical system for rapid detection of biochemical agents that catalyze a redox potential change
US5942102A (en) * 1995-11-16 1999-08-24 Usf Filtration And Separations Group Inc. Electrochemical method
US5776324A (en) * 1996-05-17 1998-07-07 Encelle, Inc. Electrochemical biosensors
US5997617A (en) * 1997-01-31 1999-12-07 Healthdyne Technologies, Inc. Pressure swing absorption system with multi-chamber canister
US6054039A (en) * 1997-08-18 2000-04-25 Shieh; Paul Determination of glycoprotein and glycosylated hemoglobin in blood
US6193865B1 (en) * 1997-09-11 2001-02-27 Usf Filtration And Separations Group, Inc. Analytic cell
US6111096A (en) * 1997-10-31 2000-08-29 Bbi Bioseq, Inc. Nucleic acid isolation and purification
US6251260B1 (en) * 1998-08-24 2001-06-26 Therasense, Inc. Potentiometric sensors for analytic determination

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060228803A1 (en) * 2005-04-08 2006-10-12 Ryan Wayne L Cellular controls for glycated hemoglobin Hb A1c
US7361513B2 (en) 2005-04-08 2008-04-22 Streck, Inc. Cellular controls for glycated hemoglobin Hb A1c
US20120247956A1 (en) * 2011-04-01 2012-10-04 Taidoc Technology Corpora Biosensor strip and manufacturing method thereof
TWI466658B (en) * 2011-04-01 2015-01-01 Taidoc Technology Corp Manufacturing method of biosensor strip and biosensor electrode pattern, and biosensor strip
EP2568281A1 (en) 2011-09-12 2013-03-13 Nova Biomedical Corporation Disposable sensor for electrochemical detection of hemoglobin
US8603309B2 (en) 2011-09-12 2013-12-10 Nova Biomedical Corporation Disposable sensor for electrochemical detection of hemoglobin
US9658181B2 (en) 2013-03-14 2017-05-23 Instrumentation Laboratory Company Whole blood hemolysis sensor
WO2015184465A1 (en) * 2014-05-30 2015-12-03 The Regents Of The University Of California Strip-based electrochemical sensors for quantitative analysis of analytes
US10364452B2 (en) 2014-05-30 2019-07-30 The Regents Of The University Of California Strip-based electrochemical sensors for quantitative analysis of analytes
US11471092B2 (en) * 2016-06-20 2022-10-18 Greenville Neuromodulation Center Microelectrode with hemoglobin or iron sensor and methods of guiding same

Also Published As

Publication number Publication date
US6632349B1 (en) 2003-10-14

Similar Documents

Publication Publication Date Title
US6632349B1 (en) Hemoglobin sensor
WO2002006828A2 (en) Hemoglobin sensor
US6638415B1 (en) Antioxidant sensor
US6413411B1 (en) Method and apparatus for amperometric diagnostic analysis
EP0406304B1 (en) Method and apparatus for amperometric diagnostic analysis
US8801907B2 (en) Electrochemical cell
EP0546536B1 (en) Biosensor and method of quantitative analysis using the same
US7967962B2 (en) Sensors
KR100495935B1 (en) Small volume in vitro analyte sensor and methods
KR100628860B1 (en) Electrochemical Sensor
AU2001276888A1 (en) Antioxidant sensor
US20040206636A1 (en) Electrochemical cell
RU2271536C2 (en) Method for measuring hemoglobin quantity
IL153582A (en) Hemoglobin sensor
CA1340516C (en) Method and apparatus for amperometric diagnostic analysis

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION